These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2679 related articles for article (PubMed ID: 7763085)

  • 1. Expression of the p53 protein in malignant melanomas as a prognostic indicator.
    Yamamoto M; Takahashi H; Saitoh K; Horikoshi T; Takahashi M
    Arch Dermatol Res; 1995; 287(2):146-51. PubMed ID: 7763085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
    Karjalainen JM; Eskelinen MJ; Kellokoski JK; Reinikainen M; Alhava EM; Kosma VM
    Br J Cancer; 1999 Feb; 79(5-6):895-902. PubMed ID: 10070887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of p53 over-expression in thin melanomas.
    Sparrow LE; English DR; Heenan PJ; Dawkins HJ; Taran J
    Melanoma Res; 1995 Dec; 5(6):387-92. PubMed ID: 8589612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications.
    Weiss J; Heine M; Körner B; Pilch H; Jung EG
    Br J Dermatol; 1995 Jul; 133(1):23-31. PubMed ID: 7669636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of P53 protein in cutaneous melanoma].
    Casazza S; Gambini C; Tunesi G; Rovida S; Caruso F; Pastorino A; Canepa M
    Pathologica; 1993; 85(1097):335-42. PubMed ID: 8233650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin.
    Vogt T; Zipperer KH; Vogt A; Hölzel D; Landthaler M; Stolz W
    Histopathology; 1997 Jan; 30(1):57-63. PubMed ID: 9023558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumour thickness in cutaneous malignant melanoma.
    Jeffrey I; Royston P; Sowter C; Slavin G; Price A; Pomerance A; Goolamali S; Pinto D
    J Clin Pathol; 1983 Jan; 36(1):51-6. PubMed ID: 6822677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
    Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
    Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma.
    Ross DA; Wilson GD
    Br J Surg; 1997 Jun; 84(6):803-7. PubMed ID: 9189093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
    Talve L; Kainu J; Collan Y; Ekfors T
    Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
    Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
    Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein-overexpression as a prognostic marker in melanoma.
    Weinlich G
    G Ital Dermatol Venereol; 2009 Feb; 144(1):27-38. PubMed ID: 19218909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance.
    Loggini B; Rinaldi I; Pingitore R; Cristofani R; Castagna M; Barachini P
    Tumori; 2001; 87(3):179-86. PubMed ID: 11504374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.
    Sviatoha V; Rundgren A; Tani E; Hansson J; Kleina R; Skoog L
    Cytopathology; 2002 Feb; 13(1):11-21. PubMed ID: 11985564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
    Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
    Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 134.